Market Overview:
The global sterile artificial tears market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of dry eye syndrome (DES) and contact lens-related problems. In addition, rising awareness about the benefits of using artificial tears for treating DES and other ocular problems is also contributing to the growth of this market. Based on type, the global sterile artificial tears market is segmented into artificial tear liquid and artificial tear ointment. The liquid form dominates this segment owing to its easy availability and user-friendly nature. However, in terms of value share, the ointment form is expected to grow at a higher rate during the forecast period as it offers better lubrication than liquids for people with severe cases of DES or those using contact lenses regularly. Based on application, dry eyes treatment accounts for majority share in terms of value in this market followed by contact lenses moisten and others segments respectively. Dry eyes treatment dominates due high prevalence rateof dry eye syndrome across all regions globally coupled with rising awareness among people regarding various treatments available for DES such as use if Artificial Tears .
Product Definition:
Sterile artificial tears are used to lubricate and moisten the eyes. They may be used to relieve symptoms of dry eye, such as burning, stinging, or itching.
Artificial Tear Liquid:
Artificial tear liquid is a sterile water based solution that helps in maintaining the integrity of ocular tissue. It also provides lubrication and reduces dry eye symptoms such as itchy eyes, burning sensation, light sensitivity or blurred vision.
Artificial Tear Ointment:
Artificial tear ointment is a topical skin preparation used to prevent or slow down the progression of dry eye disease. It works by forming a protective film over the cornea, which helps in reducing evaporation and irritation caused by dryness. The active ingredient in artificial tear ointment varies according to its type such as cyclosporine, fluoroxetine, and corticosteroids among others.
Application Insights:
The others application segment held the largest share of more than 50.0% in 2017. This is due to the increasing demand for AToT products from other application areas such as ophthalmic gels and lotions, corneal care, and skin care among others. In addition, factors such as aging population with dry eyes or contact lens problems will boost product demand over the forecast period.
Dry eyes treatment is expected to be one of the fastest-growing segments owing to various benefits offered by artificial tears including comfort and relief from burning sensation along with improving vision in less time without glasses or contacts required for healing naturally.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D activities, presence of key players and high disposable income of consumers in this region. In addition, rise in prevalence of dry eye disease is anticipated to drive demand for artificial tears over the forecast period as these products help reduce irritation and inflammation associated with it.
Asia Pacific is expected to witness lucrative growth over the coming years owing to increase spending power and growing population especially in India & China regions which are majorly affected by Dry Eye Disease (DES). These factors along with favorable government initiatives are anticipated boost regional market growth during the estimated time frame.
Growth Factors:
- Increasing prevalence of dry eye syndrome: The increasing prevalence of dry eye syndrome is one of the key growth drivers for the global sterile artificial tears market. Dry eye syndrome is a condition that affects millions of people across the globe, and this number is expected to increase in the coming years due to various factors such as changing lifestyles, growing pollution levels, and increasing use of digital devices. This will create demand for sterile artificial tears products and drive market growth.
- Rising awareness about benefits of using sterile artificial tears: There is a growing awareness among consumers about the benefits of using sterile artificial tears products over conventional lubricating eyedrops products available in the market. This has led to an increase in adoption rates for these products, thereby driving market growth.
- Technological advancements in manufacturing process: The technological advancements taking place in the manufacturing process for sterile artificial tears are helping to improve product quality and efficacy while reducing production costs simultaneously. This is resulting in an increase in demand for these products, thereby propelling market growth further.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sterile Artificial Tears Market Research Report
By Type
Artificial Tear Liquid, Artificial Tear Ointment
By Application
Dry Eyes Treatment, Contact Lenses Moisten, Others
By Companies
Allergan, Alcon, Bausch & Lomb, Johnson & Johnson, Santen Pharmaceutical, Ursapharm, Rohto, Similasan Corporation, Ocusoft, Nicox, Allergan, Wuhan Yuanda
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
151
Number of Tables & Figures
106
Customization Available
Yes, the report can be customized as per your need.
Global Sterile Artificial Tears Market Report Segments:
The global Sterile Artificial Tears market is segmented on the basis of:
Types
Artificial Tear Liquid, Artificial Tear Ointment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dry Eyes Treatment, Contact Lenses Moisten, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Alcon
- Bausch & Lomb
- Johnson & Johnson
- Santen Pharmaceutical
- Ursapharm
- Rohto
- Similasan Corporation
- Ocusoft
- Nicox
- Allergan
- Wuhan Yuanda
Highlights of The Sterile Artificial Tears Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Artificial Tear Liquid
- Artificial Tear Ointment
- By Application:
- Dry Eyes Treatment
- Contact Lenses Moisten
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sterile Artificial Tears Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sterile artificial tears are a type of eye drop that are used to treat dry eyes. They contain a solution that helps to restore moisture and protect the eyes from infection.
Some of the key players operating in the sterile artificial tears market are Allergan, Alcon, Bausch & Lomb, Johnson & Johnson, Santen Pharmaceutical, Ursapharm, Rohto, Similasan Corporation, Ocusoft, Nicox, Allergan, Wuhan Yuanda.
The sterile artificial tears market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sterile Artificial Tears Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sterile Artificial Tears Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sterile Artificial Tears Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sterile Artificial Tears Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sterile Artificial Tears Market Size & Forecast, 2018-2028
4.5.1 Sterile Artificial Tears Market Size and Y-o-Y Growth
4.5.2 Sterile Artificial Tears Market Absolute $ Opportunity
Chapter 5 Global Sterile Artificial Tears Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Sterile Artificial Tears Market Size Forecast by Type
5.2.1 Artificial Tear Liquid
5.2.2 Artificial Tear Ointment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Sterile Artificial Tears Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Sterile Artificial Tears Market Size Forecast by Applications
6.2.1 Dry Eyes Treatment
6.2.2 Contact Lenses Moisten
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sterile Artificial Tears Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sterile Artificial Tears Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Sterile Artificial Tears Analysis and Forecast
9.1 Introduction
9.2 North America Sterile Artificial Tears Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Sterile Artificial Tears Market Size Forecast by Type
9.6.1 Artificial Tear Liquid
9.6.2 Artificial Tear Ointment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Sterile Artificial Tears Market Size Forecast by Applications
9.10.1 Dry Eyes Treatment
9.10.2 Contact Lenses Moisten
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Sterile Artificial Tears Analysis and Forecast
10.1 Introduction
10.2 Europe Sterile Artificial Tears Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Sterile Artificial Tears Market Size Forecast by Type
10.6.1 Artificial Tear Liquid
10.6.2 Artificial Tear Ointment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Sterile Artificial Tears Market Size Forecast by Applications
10.10.1 Dry Eyes Treatment
10.10.2 Contact Lenses Moisten
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Sterile Artificial Tears Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Sterile Artificial Tears Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Sterile Artificial Tears Market Size Forecast by Type
11.6.1 Artificial Tear Liquid
11.6.2 Artificial Tear Ointment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Sterile Artificial Tears Market Size Forecast by Applications
11.10.1 Dry Eyes Treatment
11.10.2 Contact Lenses Moisten
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Sterile Artificial Tears Analysis and Forecast
12.1 Introduction
12.2 Latin America Sterile Artificial Tears Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Sterile Artificial Tears Market Size Forecast by Type
12.6.1 Artificial Tear Liquid
12.6.2 Artificial Tear Ointment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Sterile Artificial Tears Market Size Forecast by Applications
12.10.1 Dry Eyes Treatment
12.10.2 Contact Lenses Moisten
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Sterile Artificial Tears Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Sterile Artificial Tears Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Sterile Artificial Tears Market Size Forecast by Type
13.6.1 Artificial Tear Liquid
13.6.2 Artificial Tear Ointment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Sterile Artificial Tears Market Size Forecast by Applications
13.10.1 Dry Eyes Treatment
13.10.2 Contact Lenses Moisten
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sterile Artificial Tears Market: Competitive Dashboard
14.2 Global Sterile Artificial Tears Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Alcon
14.3.3 Bausch & Lomb
14.3.4 Johnson & Johnson
14.3.5 Santen Pharmaceutical
14.3.6 Ursapharm
14.3.7 Rohto
14.3.8 Similasan Corporation
14.3.9 Ocusoft
14.3.10 Nicox
14.3.11 Allergan
14.3.12 Wuhan Yuanda
